Global post-transcriptional regulators in P. aeruginosa
铜绿假单胞菌的全局转录后调节因子
基本信息
- 批准号:10524023
- 负责人:
- 金额:$ 57.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-12-02 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Abstract
Pseudomonas aeruginosa is an important opportunistic pathogen of humans. It is the principal cause of
morbidity and mortality in Cystic Fibrosis (CF) patients, a major cause of hospital-acquired pneumonia and is
particulary problematic in burn wound infections. Hfq is a conserved global post-transcriptional regulator that is
required for the virulence of P. aeruginosa. In other organisms Hfq is best known for its ability to promote the
base-pairing between small regulatory RNAs (sRNAs) and their target transcripts. Hfq-promoted interaction
between an sRNA and its mRNA target typically functions to repress translation of the target, although Hfq can
also inhibit translation in an sRNA-independent fashion. We have found that in P. aeruginosa Hfq associates
with hundreds of transcripts as they emerge from RNA polymerase. Because transcription and translation are
coupled in bacteria, the interaction of Hfq with these nascent transcripts presumably allows this RNA-binding
protein to exert its regulatory effects on translation at the earliest possible opportunity. In Aim 1 we propose to
identify the targets of all the sRNAs that interact with Hfq in P. aeruginosa and determine whether these
sRNAs frequently work in conjunction with Hfq on nascent transcripts. The interaction of Hfq with nascent
transcripts has important implications for how transcript abundance can be controlled; specifically, Hfq-
dependent inhibition of the translation of nascent transcripts would render them accessible to the transcription
termination factor Rho or to ribonucleases. In Aim 1 we will determine whether Hfq reduces the abundance of
those nascent transcripts it binds through effects on Rho-mediated transcription termination or through effects
on RNA degradation. We have found that a second global post-transcriptional regulator in P. aeruginosa called
RsmA also targets hundreds of nascent transcripts, including many of those that are targeted by Hfq. RsmA is
a key regulator of the switch between acute and chronic infection phenotypes in P. aeruginosa and in Aim 2 we
will investigate whether Hfq and RsmA modulate each other’s activities through competition or cooperation on
common targets. Like Hfq, the binding of RsmA to target mRNA species typically inhibits their translation. In
Aim 3 we propose to determine whether the interaction of RsmA with nascent transcripts influences their
abundance through effects on Rho-mediated transcription termination or effects on RNA degradation. The
experiments outlined in this proposal are expected to illuminate how Hfq and RsmA control gene expression
through their widespread targeting of nascent transcripts. The co-transcriptional activities of these global post-
transcriptional regulators have been underexplored and our proposed studies may have implications not only
for how Hfq and RsmA impact the virulence of P. aeruginosa, but also for how their orthologs influence
virulence gene expression in other pathogenic bacteria that contain them.
抽象的
铜绿假单胞菌是人类的重要机会病原体。这是
囊性纤维化(CF)患者的发病率和死亡率,这是医院获得性肺炎的主要原因,IS
在烧伤伤口感染中特别有问题。 HFQ是一个配置的全局转录后调节器,是
铜绿假单胞菌病毒所必需的。在其他生物体中,HFQ以促进它的能力而闻名
小调节性RNA(SRNA)及其目标转录本之间的基础配对。 HFQ促进的相互作用
在SRNA及其mRNA靶标之间通常可以反映目标的翻译,尽管HFQ可以
还以独立于SRNA的方式抑制翻译。我们发现在铜绿假单胞菌HFQ Associates中
从RNA聚合酶出来时,有数百个转录本。因为转录和翻译是
耦合在细菌中,HFQ与这些新生的转录本的相互作用大概可以使这种RNA结合
蛋白质以最早可能的机会对翻译执行调节作用。在目标1中,我们建议
确定所有与铜绿假单胞菌中与HFQ相互作用的SRNA的靶标
SRNA经常与HFQ一起在新生的转录本上使用。 HFQ与新生的相互作用
成绩单对如何控制转录本丰度具有重要意义。具体而言,HFQ-
对新生转录本的翻译的依赖性抑制作用将使它们可访问转录
终止因子Rho或丝带酶。在AIM 1中,我们将确定HFQ是否减少
那些新生的转录本通过对Rho介导的转录终止的影响或通过影响而结合
关于RNA降解。我们发现,铜绿假单胞菌中的第二个全球转录后调节器称为
RSMA还针对数百个新生的转录本,包括许多由HFQ靶向的。 RSMA是
铜绿假单胞菌和AIM 2中急性和慢性感染表型之间切换的关键调节器
将调查HFQ和RSMA是否通过竞争或合作来调节彼此的活动
常见目标。像HFQ一样,RSMA对靶向mRNA物种的结合通常会抑制其翻译。在
目的3我们建议确定RSMA与新生转录本的相互作用是否影响其
通过对Rho介导的转录终止的影响或对RNA降解的影响的抽象。这
预计该提案中概述的实验将阐明HFQ和RSMA控制基因表达如何
通过其宽度靶向新生的转录本。这些全球后的共同交易活动 -
转录调节剂没有被逐渐解散,我们提出的研究不仅具有影响
关于HFQ和RSMA如何影响铜绿假单胞菌的病毒,以及它们的直系同源物如何影响
含有它们的其他致病细菌中的毒力基因表达。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
SIMON L DOVE的其他基金
Identification of RNA-binding proteins in Pseudomonas aeruginosa
铜绿假单胞菌中 RNA 结合蛋白的鉴定
- 批准号:1042891410428914
- 财政年份:2022
- 资助金额:$ 57.91万$ 57.91万
- 项目类别:
Identification of RNA-binding proteins in Pseudomonas aeruginosa
铜绿假单胞菌中 RNA 结合蛋白的鉴定
- 批准号:1061359010613590
- 财政年份:2022
- 资助金额:$ 57.91万$ 57.91万
- 项目类别:
Identity, function and control of Francisella effectors encoded outside its pathogenicity island
弗朗西斯菌致病岛外编码的效应子的身份、功能和控制
- 批准号:1018751310187513
- 财政年份:2019
- 资助金额:$ 57.91万$ 57.91万
- 项目类别:
Identity, function and control of Francisella effectors encoded outside its pathogenicity island
弗朗西斯菌致病岛外编码的效应子的身份、功能和控制
- 批准号:97968059796805
- 财政年份:2019
- 资助金额:$ 57.91万$ 57.91万
- 项目类别:
Global post-transcriptional regulators in P. aeruginosa
铜绿假单胞菌的全局转录后调节因子
- 批准号:98959749895974
- 财政年份:2019
- 资助金额:$ 57.91万$ 57.91万
- 项目类别:
Identity, function and control of Francisella effectors encoded outside its pathogenicity island
弗朗西斯菌致病岛外编码的效应子的身份、功能和控制
- 批准号:1066826010668260
- 财政年份:2019
- 资助金额:$ 57.91万$ 57.91万
- 项目类别:
A signaling pathway governing growth and antibiotic sensitivity in Pseudomonas aeruginosa
控制铜绿假单胞菌生长和抗生素敏感性的信号通路
- 批准号:98070239807023
- 财政年份:2019
- 资助金额:$ 57.91万$ 57.91万
- 项目类别:
Global post-transcriptional regulators in P. aeruginosa
铜绿假单胞菌的全局转录后调节因子
- 批准号:1006412510064125
- 财政年份:2019
- 资助金额:$ 57.91万$ 57.91万
- 项目类别:
Global post-transcriptional regulators in P. aeruginosa
铜绿假单胞菌的全局转录后调节因子
- 批准号:1030762810307628
- 财政年份:2019
- 资助金额:$ 57.91万$ 57.91万
- 项目类别:
Identity, function and control of Francisella effectors encoded outside its pathogenicity island
弗朗西斯菌致病岛外编码的效应子的身份、功能和控制
- 批准号:1041591110415911
- 财政年份:2019
- 资助金额:$ 57.91万$ 57.91万
- 项目类别:
相似国自然基金
通过分子链“配对混合”调控立构复合聚乳酸熔体稳定性的基础研究
- 批准号:52373044
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
父本选配对尾叶桉F1杂种优势的遗传基础研究
- 批准号:31600545
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Susceptibility and resistance of multidrug-resistant gram-negative bacteria to novel beta-lactam/beta-lactamase inhibitor combinations
多重耐药革兰氏阴性菌对新型β-内酰胺/β-内酰胺酶抑制剂组合的敏感性和耐药性
- 批准号:1074867610748676
- 财政年份:2023
- 资助金额:$ 57.91万$ 57.91万
- 项目类别:
Spacer acquisition during the type III-A CRISPR-Cas immune response
III-A 型 CRISPR-Cas 免疫反应期间间隔区的获取
- 批准号:1063898010638980
- 财政年份:2023
- 资助金额:$ 57.91万$ 57.91万
- 项目类别:
RNA regulation associated with mcr11-abmR locus in M. tuberculosis
结核分枝杆菌中与 mcr11-abmR 位点相关的 RNA 调控
- 批准号:1088458510884585
- 财政年份:2023
- 资助金额:$ 57.91万$ 57.91万
- 项目类别:
Exploring envelope stress response toxicity and regulation in gram-negative bacteria
探索革兰氏阴性菌的包膜应激反应毒性和调节
- 批准号:1062950510629505
- 财政年份:2023
- 资助金额:$ 57.91万$ 57.91万
- 项目类别:
Small RNA based control of zinc homeostasis in Streptococcus pneumoniae
基于小RNA的肺炎链球菌锌稳态控制
- 批准号:1062544810625448
- 财政年份:2022
- 资助金额:$ 57.91万$ 57.91万
- 项目类别: